{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:17:08Z","timestamp":1792192628495,"version":"4.4.0"},"reference-count":46,"publisher":"FapUNIFESP (SciELO)","issue":"2","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Gastroenterol."],"abstract":"<jats:p>ABSTRACT  BACKGROUND:  Gastroesophageal reflux disease (GERD) is one of the most prevalent gastrointestinal diseases. GERD generates significant impairment in patients\u2019 quality of life and it is associated to relevant medical resources utilization. A better understanding of GERD pathophysiology in the past five decades has favored the evolution of therapeutic strategies from non-drug interventions and antacids to more efficacious and safer alternatives.  OBJECTIVE:  To summarize data about the historical evolution of GERD management in Brazil, focusing on medical therapy and addressing evidence on efficacy and safety of drug classes currently recommended.  METHODS:  A narrative review was conducted by systematizing information about discoveries on GERD pathophysiology. We also addressed efficacy and safety of medications currently used to reduce symptoms and improve endoscopic healing of esophageal lesions. A structured search on Pubmed was performed to identify systematic reviews and meta-analysis investigating GERD outcomes positively impacted by proton pump inhibitors (PPIs), the first choice of pharmacotherapy for the disease.  RESULTS:  The chronological development of therapeutic measures for GERD in Brazil evolved from lifestyle interventions with relative poor effect on symptoms related to esophageal acid exposure, particularly heartburn, to effective and safe pharmacological interventions such as histamine H2-receptor antagonists and PPIs. In the present days, some drug classes play a minor role in disease management, namely prokinetics and antacids, due to their reduced efficacy and relevant safety concerns (particularly with prokinetics). The main challenge for prescribers and researchers seems to be finding long-acting acid suppressants strategies able to ameliorate patients\u2019 symptoms and quality of life, thereafter, reducing medical resource consumption. The dual delayed-release PPI dexlansoprazole seems to respond for some of the limitations other PPIs have.  CONCLUSION:  Recognizing the historical evolution of GERD management can help care providers to better understand therapeutic options for their patients, as well as focus on unmet needs that deserve further attention. PPIs are still the first choice therapy, with good evidence in favor of their efficacy, despite some safety concerns. However, as with any medical intervention, it is recommended to prescribe PPIs for patients with clear indication, using adequate dosing and monitoring for adverse events.<\/jats:p>","DOI":"10.1590\/s0004-2803.201900000-41","type":"journal-article","created":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T15:26:21Z","timestamp":1566660381000},"page":"202-208","source":"Crossref","is-referenced-by-count":12,"title":["HISTORICAL PERSPECTIVE OF GASTROESOPHAGEAL REFLUX DISEASE CLINICAL TREATMENT"],"prefix":"10.1590","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2260-9146","authenticated-orcid":false,"given":"Schlioma","family":"ZATERKA","sequence":"first","affiliation":[{"name":"Universidade de Campinas,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4429-0447","authenticated-orcid":false,"given":"Sandra Beatriz","family":"MARION","sequence":"additional","affiliation":[{"name":"Hospital Universit\u00e1rio Cajuru,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2898-717X","authenticated-orcid":false,"given":"Fabiana","family":"ROVEDA","sequence":"additional","affiliation":[{"name":"Takeda Brasil Ringgold Standard Institution,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4842-1552","authenticated-orcid":false,"given":"Marcos Ant\u00f4nio","family":"PERROTTI","sequence":"additional","affiliation":[{"name":"Takeda Brasil Ringgold Standard Institution,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3030-6687","authenticated-orcid":false,"given":"Decio","family":"CHINZON","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2019,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0399-8320(06)73189-X","article-title":"Gastroesophageal reflux disease in primary care. Prevalence, epidemiology and Quality of Life of patients","volume":"30","author":"Bruley Des Varannes S","year":"2006","journal-title":"Gastroenterol Clin Biol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/MCG.0b013e31815ea27b","article-title":"Gastroesophageal reflux disease (GERD): risk factors, and impact on quality of life-a population-based study","volume":"43","author":"Eslick GD","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.08.045","article-title":"Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States","volume":"149","author":"Peery AF","year":"2015","journal-title":"Gastroenterology"},{"key":"ref4","series-title":"Doen\u00e7a do Refluxo Gastroesof\u00e1gico: Diagn\u00f3stico. Diretrizes Cl\u00ednicas na Sa\u00fade Suplementar","first-page":"1","year":"2011"},{"issue":"3","key":"ref5","first-page":"251","article-title":"Projeto Diretrizes - Refluxo Gastroesof\u00e1gico: Diagn\u00f3stico e Tratamento","volume":"50","year":"2006","journal-title":"Rev AMRIGS"},{"key":"ref6","article-title":"Global Perspective on Gastroesophageal Reflux Disease","author":"Hunt R","year":"2015","journal-title":"World Gastroenterol Organ Glob Guidel GERD"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/gutjnl-2016-313589","article-title":"Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis","volume":"67","author":"Eusebi LH","year":"2018","journal-title":"Gut"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1590\/S0004-28032005000200011","article-title":"Prevalence of heartburn and gastroesophageal reflux disease in the urban Brazilian population","volume":"42","author":"Moraes-Filho JPP","year":"2005","journal-title":"Arq Gastroenterol"},{"key":"ref9","first-page":"73","article-title":"Preval\u00eancia da doen\u00e7a do refluxo gastroesof\u00e1gico: estudo populacional em Porto Alegre, Rio Grande do Sul","volume":"19","author":"Pereira-Lima J","year":"2000","journal-title":"Gastroenterol Endosc Dig"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"17388","DOI":"10.3748\/wjg.v20.i46.17388","article-title":"Epidemiology of upper gastrointestinal symptoms in Brazil (EpiGastro): a population-based study according to sex and age group","volume":"20","author":"do Ros\u00e1rio Dias de Oliveira Latorre M","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1365-2036.2006.03122.x","article-title":"From 1906 to 2006 - a century of major evolution of understanding of gastrooesophageal reflux disease","volume":"24","author":"Dent J","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1080\/14656566.2017.1361407","article-title":"A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD)","volume":"18","author":"Savarino E","year":"2017","journal-title":"Expert Opin Pharmacother"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000091298","article-title":"Acid Suppression Therapy: Where Do We Go from Here?","volume":"24","author":"Scarpignato C","year":"2006","journal-title":"Dig Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1001\/archinte.166.9.965","article-title":"Are Lifestyle Measures Effective in Patients With Gastroesophageal Reflux Disease?","volume":"166","author":"Kaltenbach T","year":"2006","journal-title":"Arch Intern Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0163-7258(03)00015-9","article-title":"Pharmacological control of gastric acid secretion for the treatment of acid-related peptic disease: past, present, and future","volume":"98","author":"Aihara T","year":"2003","journal-title":"Pharmacol Ther"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.3748\/wjg.15.1690","article-title":"Body weight, lifestyle, dietary habits and gastroesophageal reflux disease","volume":"15","author":"Festi D","year":"2009","journal-title":"World J Gastroenterol"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2015.04.176","article-title":"Lifestyle Intervention in Gastroesophageal Reflux Disease","volume":"14","author":"Ness-Jensen E","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1365-2036.2009.04146.x","article-title":"Systematic review: the effects of conservative and surgical treatment for obesity on gastro-oesophageal reflux disease","volume":"30","author":"De Groot NL","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"ref19","first-page":"210","article-title":"Diagn\u00f3stico e tratamento da doen\u00e7a do refluxo gastroesof\u00e1gico","volume":"27","author":"Henry MACA","year":"2014","journal-title":"Arq Bras Cir Dig"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1590\/S0004-28032010000100017","article-title":"Guidelines for the diagnosis and management of gastroesophageal reflux disease: an evidence-based consensus","volume":"47","author":"Moraes-Filho JPP","year":"2010","journal-title":"Arq Gastroenterol"},{"issue":"5","key":"ref21","article-title":"Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease","author":"Sigterman KE","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.gie.2007.05.027","article-title":"Role of endoscopy in the management of GERD","volume":"66","author":"Lichtenstein DR","year":"2007","journal-title":"Gastrointest Endosc"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ajg.2012.444","article-title":"Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease","volume":"108","author":"Katz PO","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"808","DOI":"10.7326\/0003-4819-157-11-201212040-00008","article-title":"Upper Endoscopy for Gastroesophageal Reflux Disease: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians","volume":"157","author":"Shaheen NJ","year":"2012","journal-title":"Ann Intern Med"},{"key":"ref25","series-title":"Di\u00e1rio Oficial da Uni\u00e3o","volume-title":"Portaria n\u00b0 55, de 05 de dezembro de 1990: omeprazol","year":"1990"},{"key":"ref26","series-title":"Di\u00e1rio Oficial da Uni\u00e3o","volume-title":"Portaria no 22 de 1o de mar\u00e7o de 1994: lansoprazol","year":"1994"},{"key":"ref27","series-title":"Di\u00e1rio Oficial da Uni\u00e3o","volume-title":"Portaria no 45, de 6 de abril de 1995: pantoprazol","year":"1995"},{"key":"ref28","series-title":"Portaria no 342 de 15 de abril de 1999: rabeprazol","year":"1999"},{"key":"ref29","series-title":"Di\u00e1rio Oficial da Uni\u00e3o","volume-title":"Resolu\u00e7\u00e3o-RE no 512\/MS\/ANVS, de 28 de dezembro de 2000: esomeprazol","year":"2000"},{"key":"ref30","series-title":"Di\u00e1rio Oficial da Uni\u00e3o","volume-title":"Resolu\u00e7\u00e3o - RE no 317, de 27 de janeiro de 2012. Registro de medicamento novo: dexlansoprazol","year":"2012"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"32126","DOI":"10.1038\/srep32126","article-title":"The efficacy and safety of proton-pump inhibitors in treating patients with non-erosive reflux disease: a network meta-analysis","volume":"6","author":"Chen L","year":"2016","journal-title":"Sci Rep"},{"key":"ref32","article-title":"Comparative effectiveness and acceptability of the FDA-licensed proton pump inhibitors for erosive esophagitis: A PRISMA-compliant network meta-analysis","volume":"96","author":"Li M-J","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1365-2036.2009.03933.x","article-title":"Clinical trials: Healing of erosive oesophagitis with dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed-release formulation - Results from two randomized controlled studies","volume":"29","author":"Sharma P","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/ajg.2010.458","article-title":"The Effect of Dexlansoprazole MR on Nocturnal Heartburn and GERD-Related Sleep Disturbances in Patients With Symptomatic GERD","volume":"106","author":"Fass R","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/apt.12349","article-title":"Indirect comparison of randomised controlled trials: comparative efficacy of dexlansoprazole vs. esomeprazole in the treatment of gastro-oesophageal reflux disease","volume":"38","author":"Wu MS","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/MCG.0b013e3182333820","article-title":"Recent safety concerns with proton pump inhibitors","volume":"46","author":"Chen J","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-017-0804-x","article-title":"When is proton pump inhibitor use appropriate?","volume":"15","author":"Yadlapati R","year":"2017","journal-title":"BMC Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/ajcp\/110.5.615","article-title":"Proton pump inhibitor-associated gastric polyps: A retrospective analysis of their frequency, and endoscopic, histologic, and ultrastructural characteristics","volume":"110","author":"Choudhry U","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/nrgastro.2011.272","article-title":"The risks of PPI therapy","volume":"9","author":"Moayyedi P","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1365-2036.2005.02454.x","article-title":"Long-term use of acid suppression started inappropriately during hospitalization","volume":"21","author":"Zink DA","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/apt.13450","article-title":"Risk of gastric cancer, gastrointestinal cancers and other cancers: a comparison of treatment with pantoprazole and other proton pump inhibitors","volume":"43","author":"Schneider JL","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"ref42","article-title":"Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort study","volume":"3","author":"Antoniou T","year":"2015","journal-title":"C Open"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1442-2050.2011.01227.x","article-title":"Low levels of adherence with proton pump inhibitor therapy contribute to therapeutic failure in gastroesophageal reflux disease","volume":"25","author":"Dal-Paz K","year":"2012","journal-title":"Dis Esophagus"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1590\/S0004-28032012000400012","article-title":"Refractory gastroesophageal reflux disease","volume":"49","author":"Moraes-Filho JPP","year":"2012","journal-title":"Arq Gastroenterol"},{"key":"ref45","series-title":"Discovery and Development of Proton Pump Inhibitors","first-page":"1","author":"Satoh H","year":"2013"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pharmthera.2016.08.001","article-title":"Potassium-competitive acid blockers: Advanced therapeutic option for acid-related diseases","volume":"168","author":"Inatomi N","year":"2016","journal-title":"Pharmacol Ther"}],"container-title":["Arquivos de Gastroenterologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/ag\/v56n2\/1678-4219-ag-56-02-202.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T14:57:24Z","timestamp":1581433044000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-28032019000200202&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":46,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,6]]}},"alternative-id":["S0004-28032019000200202"],"URL":"https:\/\/doi.org\/10.1590\/s0004-2803.201900000-41","relation":{},"ISSN":["1678-4219","0004-2803"],"issn-type":[{"value":"1678-4219","type":"electronic"},{"value":"0004-2803","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}